Your browser doesn't support javascript.
loading
Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumors.
Borazanci, E; Schram, A M; Garralda, E; Brana, I; Vieito Villar, M; Spreafico, A; Oliva, M; Lakhani, N J; Hoffman, K; Hallett, R M; Maetzel, D; Hua, F; Hilbert, J; Giblin, P; Anido, J; Kelly, A; Vickers, P J; Wasserman, R; Seoane, J; Siu, L L; Hyman, D M; Hoff, D V; Tabernero, J.
Afiliación
  • Borazanci E; HonorHealth, Scottsdale, USA. Electronic address: eborazanci@honorhealth.com.
  • Schram AM; Memorial Sloan Kettering Cancer Center, New York, USA.
  • Garralda E; Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), Barcelona, Spain.
  • Brana I; Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), Barcelona, Spain.
  • Vieito Villar M; Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), Barcelona, Spain.
  • Spreafico A; Princess Margaret Cancer Centre, Toronto, Canada.
  • Oliva M; Princess Margaret Cancer Centre, Toronto, Canada.
  • Lakhani NJ; START Midwest, Grand Rapids, USA.
  • Hoffman K; Northern Biologics, Inc., Toronto, Canada.
  • Hallett RM; Northern Biologics, Inc., Toronto, Canada.
  • Maetzel D; Northern Biologics, Inc., Toronto, Canada.
  • Hua F; Applied BioMath, Concord, USA.
  • Hilbert J; Applied BioMath, Concord, USA.
  • Giblin P; Northern Biologics, Inc., Toronto, Canada.
  • Anido J; Northern Biologics, Inc., Toronto, Canada.
  • Kelly A; Northern Biologics, Inc., Toronto, Canada.
  • Vickers PJ; Northern Biologics, Inc., Toronto, Canada.
  • Wasserman R; Northern Biologics, Inc., Toronto, Canada.
  • Seoane J; Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Universitat Autònoma de Barcelona (UAB), CIBERONC, Barcelona.
  • Siu LL; Princess Margaret Cancer Centre, Toronto, Canada.
  • Hyman DM; Memorial Sloan Kettering Cancer Center, New York, USA.
  • Hoff DV; HonorHealth, Scottsdale, USA.
  • Tabernero J; Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), Barcelona, Spain; UVic-UCC, IOB-Quiron, Barcelona, Spain.
ESMO Open ; 7(4): 100530, 2022 08.
Article en En | MEDLINE | ID: mdl-35921760
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Límite: Humans Idioma: En Revista: ESMO Open Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Límite: Humans Idioma: En Revista: ESMO Open Año: 2022 Tipo del documento: Article